The Writing Was On The Wall For Pfizer – If You Use Volume Price Analysis!

With the US indices looking ever more fragile, it’s no surprise to see this general sentiment reflected in individual stocks, and none more so than Pfizer, which closed yesterday’s session at $43.92 per share, well off its August highs.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.